What is the long-term trend for Travere Therapeutics, Inc.'s available for sale investments?

Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s available for sale investments has grown at a -3.7% compound annual growth rate (CAGR), from $276.82M to $229.76M.

Travere Therapeutics, Inc. TVTX Available for sale investments

Available for sale investments at other companies

BridgeBio PharmaBBIO

——

Viridian Therapeutics, Inc.VRDN

——

BiogenBIIB

——

BioCryst PharmaceuticalsBCRX

——

Denali Therapeutics Inc.DNLI

——

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.2B+72.3%

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s available for sale investments?: Travere Therapeutics, Inc. (TVTX) reported available for sale investments of $186.31M in Q1 2026.
How has Travere Therapeutics, Inc.'s available for sale investments changed year-over-year?: Travere Therapeutics, Inc.'s available for sale investments decreased by 28.4% year-over-year, from $260.35M to $186.31M.
What is the long-term trend for Travere Therapeutics, Inc.'s available for sale investments?: Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s available for sale investments has grown at a -3.7% compound annual growth rate (CAGR), from $276.82M to $229.76M.